Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The way that miR-377 inhibits cells that cause prostate cancer.

2.

Cancer detection recovered following pandemic disruptions

3.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

4.

Three out of ten breast cancers detected between screenings, study finds

5.

Screening for prostate cancer: is it time to give up digital rectal examination?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot